NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Thursday reported a loss of $23 million in its fourth quarter.
On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 72 cents. Losses, adjusted for one-time gains and costs, were 27 cents per share.
The cancer diagnostic test developer posted revenue of $1.1 million in the period.
For the year, the company reported a loss of $50.2 million, or $1.65 per share. Revenue was reported as $4.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMDX at https://www.zacks.com/ap/IMDX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
